Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ocular Therapeutix (OCUL) Preferred Shares: 2013

  • Ocular Therapeutix's Preferred Shares was N/A to $8.5 million in Q4 2013 from the same period last year, while for Dec 2013 it was $8.5 million, marking a year-over-year change of. This contributed to the annual value of $8.5 million for FY2013, which is 64.29% down from last year.
  • As of Q4 2013, Ocular Therapeutix's Preferred Shares stood at $8.5 million.
  • In the past 5 years, Ocular Therapeutix's Preferred Shares registered a high of $8.5 million during Q4 2013, and its lowest value of $8.5 million during Q4 2013.
  • Moreover, its 1-year median value for Preferred Shares was $8.5 million (2013), whereas its average is $8.5 million.